TAPIR study of continuing vs stopping steroids in ANCA vasculitis in remission. Relapse at month 6 in 16% vs 4%. OR 4.22, but low rate in either group. If treated Rituximab, no difference! Merkel et al. @RheumNow #ACR24 Abstr#0774 #ACRbest https://t.co/pKa4U5L2fW https://t.co/MjzE14SeGi
Links:
A Multicenter, Randomized, Controlled Trial to Evaluate the Effects of Low-dose…
https://acrabstracts.org/abstract/a-multicenter-randomized-controlled-trial-to-…
16-11-2024